All About the Core: A Therapeutic Strategy to Prevent Protein Accumulation with Proteasome Core Particle Stimulators

Rachel A Coleman1, Darci J Trader1

  • 1Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, 575 West Stadium Avenue, West Lafayette, Indiana 47907, United States.

Insights

The proteasome degrades proteins via ubiquitin-dependent or -independent pathways. Stimulating the ubiquitin-independent system offers therapeutic potential for protein-accumulation diseases.

Area of Science:

  • Cellular Biology
  • Biochemistry
  • Enzymology

Background:

  • The proteasome is a critical cellular complex responsible for protein degradation.
  • Protein degradation occurs through ubiquitin-dependent and ubiquitin-independent mechanisms.
  • Small molecules can modulate proteasome activity, influencing protein degradation rates.

Discussion:

  • Stimulation of the ubiquitin-independent proteasome pathway holds significant therapeutic promise for protein-accumulation diseases.
  • Preliminary studies suggest this approach can effectively reduce disease-associated proteins.
  • Further research is needed to validate this mechanism in disease models.

Key Insights:

  • Targeting the ubiquitin-independent proteasome pathway is a promising therapeutic strategy.
  • Small molecules offer a means to modulate proteasome function.
  • Efficacy in disease models requires further investigation.

Outlook:

  • Validation of proteasome stimulation in disease models is crucial.
  • Determining optimal stimulation levels for therapeutic effect is necessary.
  • This research paves the way for novel treatments for protein-accumulation disorders.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.5K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.9K
The Proteasome02:18

The Proteasome

4.2K
The Proteasome Structure01:17

The Proteasome Structure

The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
1.5K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Regulated Protein Degradation02:58

Regulated Protein Degradation

It is vital to regulate the activity of enzymatic as well as non-enzymatic proteins inside the cell. This can be achieved either through creating a balance between their rate of synthesis and degradation or regulating the intrinsic activity of the protein. Both these regulation mechanisms play an essential role in the normal functioning of cells.
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
8.6K